Concepedia

Karl Kieburtz

KK

113

Publications

14.9K

Citations

59

H-Index

1989

Active since

Affiliations

University of Rochester(Current)

University of Rochester Medical Center

University of Iowa

Johns Hopkins University

Icahn School of Medicine at Mount Sinai

Karl Kieburtz is an author at University of Rochester specializing in medicine, neurology, and neuroscience.

ORCID

Top concepts

Publications per year

1989–2024

113

Publications

113

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease

Rachelle S. Doody, Rema Raman, Martin R. Farlow et al. · New England Journal of Medicine · 2013 · 1.2K citations

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

C. Warren Olanow, Karl Kieburtz, Per Odin et al. · The Lancet Neurology · 2013 · 683 citations

, , +3

Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial

William J. Marks, Raymond T. Bartus, João Siffert et al. · The Lancet Neurology · 2010 · 669 citations

, , +4

The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort

Kenneth Marek, Sohini Chowdhury, Andrew Siderowf et al. · Annals of Clinical and Translational Neurology · 2018 · 633 citations · Full text

Rows per page

1–5 of 113